Serum Soluble CD25 in Hepatocellular Carcinoma, Shall We Able to Change the Natural History?
Journal Title: Journal of Cancer and Tumor International - Year 2017, Vol 5, Issue 4
Abstract
Background: Although hepatocellular carcinoma (HCC) is one of the most common malignancy related mortality worldwide, it can be curable if detected in early stages. Axiomatically, emergence of a new marker for early prediction of HCC could enable to apply the proper treatment strategy early in the course of the disease and therefore ameliorates the outcome. Aim: To evaluate the performance of serum soluble CD25 (sCD25) in the prediction of early HCC and compare it to α-fetoprotein (AFP); the classical biomarker of HCC. Methods: Serum levels of sCD25 and AFP were measured in three groups of population; HCC group (40 patients), cirrhosis without HCC control group (20 patients) and healthy control group (20 patients). HCC group contained 20 early and 20 late stage patients according to Tumor Lymph Node Metastasis (TNM) staging system (stage I/II and III/IV respectively). Levels of both biomarkers were compared in all groups. Predictive yield of both biomarkers for early HCC was evaluated using ROC curve analysis. Results: Level of sCD25 was significantly higher in patients with HCC than in both cirrhotic controls and healthy controls (P<0.0001and 0.013 respectively). For the presence of HCC, sensitivity and specificity of sCD25 were 90% and 84.2% respectively at a cut-off value of 7 ng/ml (AUC=0.969; P<0.0001). For prediction of early HCC in patients with cirrhosis, the optimal sCD25 cutoff level was 7.15 ng/ml with sensitivity and specificity of 90% and 60% respectively (AUC=0.717; P=0.019) while sensitivity and specificity of AFP were 70% and 85% respectively at a cut-off value of 9.85 ng/ml (AUC=0.781; P=0.002) in the same settings. Conclusion: sCD25 seems to be a reliable biomarker for early detection of HCC and therefore could enhance the outcome.
Authors and Affiliations
Eman Abdel Sameea, Talaat Zakareya, Khaled Metwaly, Anas Abdel Rahman, Howyda Mohammed Kamal, Wafaa Mohammed Abdalla
Keywords
Related Articles
- EP ID EP309100
- DOI 10.9734/JCTI/2017/35735
- Views 112
- Downloads 0
Efficacy and Safety of Sorafenib in Patients with Advanced Hepatocellular Carcinoma
Aims: Advanced Hepatocellular carcinoma (HCC) is a major health problem with limited treatment options. The Sorafenib monothearpy is the only efficacious systemic treatment agent showing a survival benefit in these patie...
Antitumour Activity of Xanthium strumarium L. on Human Cervical Cancer HeLa Cells
Aim: The present investigation was aimed at assessing the antiproliferative and apoptotic potential of the hydroalcoholic extract of X. strumarium on HeLa cell line. Study Design: Antitumour activity of Xanthium strumar...
Assessment of Survivin and Lactate Dehydrogenase Isoenzyme in Leukemic Egyptian Patients
Accurate diagnosis and proper monitoring of cancer patients remain important obstacles for successful cancer treatment. The search for cancer biomarkers is carried out in order to quickly identify tumor cells and predict...
A Study on Adenexal Masses Diagnosed During Surgery in Pregnancy
Introduction: With improved antenatal care in south India, increase in number of hospital visits by the pregnant women is in turn increasing the detection rate of benign conditions like ovarian cysts during ultrasound. W...
Incidence of Multiple Mammary Tumors and Fibroadenoma in Pathological Study of Udder Affections in Camel (Camelus dromedarius)
Aims of the Study: To investigate the general histopathological pictures found in the udder tissue of camel (Camelus dromedarius) with emphasis on different types of tumors. Place and Duration of Study: The study was un...